温馨提示：本站仅提供公开网络链接索引服务，不存储、不篡改任何第三方内容，所有内容版权归原作者所有
AI智能索引来源：http://www.pr.com/press-release/694736
点击访问原文链接

New Ultrasensitive Active GLP-1 ELISA to Confidently Measure Fasted Levels of Active GLP-1 - PR.com

进入原网站 导航首页
New Ultrasensitive Active GLP-1 ELISA to Confidently Measure Fasted Levels of Active GLP-1 - PR.com Join Now Sign In Businesses Business Directory Products & Services Post Your Profile Press Releases Press Release Pricing Submit Press Release Press Release Distribution Recent Press Releases Become a Publishing Partner For Journalists Press Releases Businesses Products & Services Products Services Press Releases Submit Press Release ✕ Press Releases Press Release Pricing Submit Press Release Press Release Distribution Recent News Recent News News by Category News by US Region News by Country RSS News Feeds Business News Lifestyle News Public Interest News Technology News Become a Publishing Partner For Journalists Businesses Business Directory Products & Services Post Your Profile Join Now Sign In Press Release Pricing Recent News Business Lifestyle Public Interest Technology Press Release Pricing Create Account Press Release Pricing Submit Press Release Press Release Distribution Recent News Recent News News by Category News by US Region News by Country Become a Publishing Partner For Journalists RSS News Feeds Business News Lifestyle News Public Interest News Technology News Press Releases>Medical & Health>Diabetes>ALPCO> ALPCO ALPCO Press Releases More New Ultrasensitive Active GLP-1 ELISA to Confidently Measure Fasted Levels of Active GLP-1

ALPCO has released its new STELLUX® Chemiluminescent Ultrasensitive Active GLP-1 ELISA, the most sensitive active GLP-1 assay on the market.

Get Email Alert RSS Salem, NH, November 09, 2016 --(PR.com)-- ALPCO has released its new STELLUX® Chemiluminescent Ultrasensitive Active GLP-1 ELISA (7-36) amide, the most sensitive active GLP-1 assay on the market. The new ELISA features a sensitivity of 0.06 pM, requires 25 µL of sample, and is specific to detect GLP-1 (7-36) amide which is the major biologically active form of GLP-1. As compared to other kits on the market, the STELLUX® Chemiluminescent Ultrasensitive Active GLP-1 ELISA (7-36) amide can be run in three hours or less due to fewer incubation steps and no extraction steps.

“Studying the role of GLP-1 has become crucial to understand more about insulin resistance,” explains ALPCO’s President, Sean Conley. “We developed the new STELLUX® Chemiluminescent Ultrasensitive Active GLP-1 ELISA to allow researchers to confidently study fasted levels of GLP-1, which has proven to be a challenge when using other assays available on the market.”

The STELLUX® Chemiluminescent Ultrasensitive Active GLP-1 ELISA (7-36) amide is For Research Use Only in the United States. It has also been demonstrated that the assay does not cross-react with any pro-glucagon derived fragments.

About ALPCO
American Laboratory Products Company (ALPCO) was founded in 1991 as an importer and distributor of immunoassay-based products for the North American life science markets. The company has since grown into a premier channel representing over 60 collaborating partners from around the globe. In 2008, ALPCO expanded its capabilities with the launch of an organically developed product line focused in the area of diabetes and obesity research while also remaining true to its roots by continuing to provide “Immunoassays Beyond the Ordinary.” Contact ALPCO
Nirja Patel
1-800-592-5726
www.alpco.com Contact Categories Biotechnology Diabetes Medical & Health Medical Research Science PR.com Press Release Distribution Submit Press Release Press Release Pricing Press Release Distribution Account Create Free Account Post Your Profile Resources Recent News RSS News Feeds For Journalists Articles Company About Contact Become a Publishing Partner Terms Privacy © 2026 PR.com and its licensors Terms Privacy Follow PR.com

智能索引记录